Technical Analysis for SYBX - Synlogic, Inc.

Grade Last Price % Change Price Change
grade F 2.56 5.35% 0.13
SYBX closed up 5.35 percent on Thursday, September 19, 2019, on 1.25 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical SYBX trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Doji - Bullish? Reversal 5.35%
Wide Bands Range Expansion 5.35%
Oversold Stochastic Weakness 5.35%
Stochastic Reached Oversold Weakness 5.79%
Wide Bands Range Expansion 5.79%
Down 3 Days in a Row Weakness 5.79%

Older signals for SYBX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Synlogic, Inc., formerly Mirna Therapeutics, Inc., is engaged in the development of a novel class of living treatments, Synthetic Biotic medicines. The Company uses its proprietary Synthetic Biotic development platform. Its pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases, such as Urea Cycle Disorder (UCD) and Phenylketonuria (PKU). It is also focused on Synthetic Biotic medicines to address other conditions, including inflammatory bowel disease , cancer and metabolic conditions, such as diabetes and obesity. The Company’s synthetic biotic medicines leverages the tools and principles of synthetic biology to genetically reengineer probiotic microbes to perform or deliver critical functions missing or damaged due to disease. The Company’s pipeline includes synthetic biotic medicines for the treatment of inborn errors of metabolism (IEM). It is developing SYNB1020 for the treatment of UCD and HE. It is developing SYNB1618 for the treatment of PKU.
Cancer Biology Disease Diabetes Obesity Inflammatory Bowel Disease Inborn Errors Of Metabolism Synthetic Biology Phenylketonuria Intellectual Disability Pku Rare Genetic Diseases
Is SYBX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.59
52 Week Low 2.31
Average Volume 266,998
200-Day Moving Average 7.2114
50-Day Moving Average 4.5836
20-Day Moving Average 2.7455
10-Day Moving Average 2.529
Average True Range 0.3152
ADX 46.41
+DI 16.1553
-DI 30.6767
Chandelier Exit (Long, 3 ATRs ) 2.6344
Chandelier Exit (Short, 3 ATRs ) 3.2556
Upper Bollinger Band 3.3339
Lower Bollinger Band 2.1571
Percent B (%b) 0.34
BandWidth 42.862867
MACD Line -0.5977
MACD Signal Line -0.7136
MACD Histogram 0.1159
Fundamentals Value
Market Cap 41.68 Million
Num Shares 16.3 Million
EPS -9.33
Price-to-Earnings (P/E) Ratio -0.27
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.10
Resistance 3 (R3) 3.12 2.95 3.01
Resistance 2 (R2) 2.95 2.82 2.95 2.98
Resistance 1 (R1) 2.76 2.73 2.86 2.74 2.95
Pivot Point 2.59 2.59 2.64 2.59 2.59
Support 1 (S1) 2.40 2.46 2.50 2.38 2.17
Support 2 (S2) 2.23 2.37 2.23 2.14
Support 3 (S3) 2.04 2.23 2.11
Support 4 (S4) 2.02